The efficacy and safety of Shuanhuanglian oral solution(child type) in the treatment of acute upper respiratory tract infection (wind-heat-induced syndrome) in children: multicenter, randomized, double-blind, controlled trial

Affiliated Hospital of Liaoning University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. In line with the western medicine diagnostic criteria of acute upper respiratory tract infection;
•2. In children caused by exogenous windd-heat cold disease diagnostic criteria;
•3. Aged 1 to 7 years old;
•4. The course of the disease is not more than 24 hours;
•5. Parents or guardian signed informed consent.

•1. Do not accord with standard of this disease diagnosis and syndrome dialectical criteria;
•2. The early infantile acute infectious diseases, acute infectious laryngitis, suppurative tonsillitis, pneumonia, respiratory diseases such as bronchitis, capillary bronchitis;
•3. The temperature38.5 degree C;
•4. The pharyngeal swelling > 4 points;
•5. WBC>12x10^9/L, CRP>10mg/L;
•6. Has a history of febrile convulsion, severe malnutrition. Or with other heart, liver, kidney and hematopoietic system, such as serious primary diseases;
•7. This research institute with medicine allergic constitution and composition are allergic;
•8. Patients who are participating in clinical trials of other drugs;
•9. According to the doctor, easy to cause loss of visitor.

发起方

Affiliated Hospital of Liaoning University of Traditional Chinese Medicine